JPMorgan Chase & Co’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Buy |
117,944
+30,830
| +35% | +$60.1K | ﹤0.01% | 4405 |
|
|
2025
Q1 | $153K | Sell |
87,114
-33,001
| -27% | -$58.1K | ﹤0.01% | 4551 |
|
|
2024
Q4 | $320K | Sell |
120,115
-322,798
| -73% | -$859K | ﹤0.01% | 4349 |
|
|
2024
Q3 | $1.01M | Buy |
442,913
+366,429
| +479% | +$839K | ﹤0.01% | 3640 |
|
|
2024
Q2 | $223K | Buy |
76,484
+18,314
| +31% | +$53.5K | ﹤0.01% | 4227 |
|
|
2024
Q1 | $212K | Sell |
58,170
-40,695
| -41% | -$148K | ﹤0.01% | 4424 |
|
|
2023
Q4 | $149K | Sell |
98,865
-638
| -0.6% | -$963 | ﹤0.01% | 4592 |
|
|
2023
Q3 | $133K | Sell |
99,503
-14,088
| -12% | -$18.9K | ﹤0.01% | 4457 |
|
|
2023
Q2 | $204K | Buy |
113,591
+23,661
| +26% | +$42.6K | ﹤0.01% | 4259 |
|
|
2023
Q1 | $149K | Buy |
89,930
+23,258
| +35% | +$38.5K | ﹤0.01% | 4478 |
|
|
2022
Q4 | $128K | Buy |
66,672
+1,793
| +3% | +$3.44K | ﹤0.01% | 4395 |
|
|
2022
Q3 | $145K | Sell |
64,879
-131,820
| -67% | -$295K | ﹤0.01% | 4307 |
|
|
2022
Q2 | $638K | Sell |
196,699
-518,701
| -73% | -$1.68M | ﹤0.01% | 3744 |
|
|
2022
Q1 | $3.76M | Buy |
715,400
+43,179
| +6% | +$227K | ﹤0.01% | 2750 |
|
|
2021
Q4 | $5.71M | Buy |
672,221
+620,362
| +1,196% | +$5.27M | ﹤0.01% | 2489 |
|
|
2021
Q3 | $516K | Sell |
51,859
-8,270
| -14% | -$82.3K | ﹤0.01% | 3939 |
|
|
2021
Q2 | $560K | Buy |
+60,129
| New | +$560K | ﹤0.01% | 3929 |
|